Manchester man with Covid-19 first in UK to be given experimental arthritis drug under clinical treatment trial

www.manchestereveningnews.co.uk
2 min read
fairly difficult
Senior medics said the research was 'potentially life saving'
A man from Manchester has become the first in the UK to be given an experimental arthritis drug as part of a clinical trial to treat Covid-19.

Farhan Hamid, 41, has received a dose of otilimab - which is under investigation as a potential treatment for rheumatoid arthritis - in addition to the care he is getting at Manchester Royal Infirmary.

Mr Hamid, from south Manchester is currently in an intensive care unit at the hospital.

He was recruited to take part in the 'Oscar' (Otilimab in Severe Covid-19 Related Disease) study on September 11.

The aim of the research is to assess the effectiveness of the drug in treating the severe lung disease associated with Covid-19 infection.

(Image: PA)

The trial at Manchester Royal Infirmary, which is part of Manchester University NHS Foundation Trust, is being led by intensive care and anaesthesia consultant Andy Martin.

Dr Martin said: "The patients eligible to take part in this study are those experiencing very severe lung difficulties due to Covid-19 infection and are receiving oxygen or ventilator support.

Sign up to the free MEN email newsletter Get the latest updates from across Greater Manchester direct to your inbox with the free MEN newsletter You can sign up very simply by following the instructions here

"We are conducting this study to see whether otilimab - which is under investigation as a potential treatment for rheumatoid arthritis - could also potentially ease the effect of coronavirus on the lungs, dampening the impact of the virus on the immune system."

(Image: PA)

Funded by GlaxoSmithKline…
Read full article